Literature DB >> 12965938

Is Chlamydia pneumoniae present in cerebrospinal fluid of multiple sclerosis patients?

Maria Lucia C Tondella, Geethani Galagoda, Charlotte A Gaydos, Jens Boman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12965938      PMCID： PMC193904          DOI： 10.1128/cdli.10.5.977-978.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  15 in total

1.  Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS.

Authors:  J Boman; P M Roblin; P Sundström; M Sandström; M R Hammerschlag
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

Review 2.  Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

Authors:  S F Dowell; R W Peeling; J Boman; G M Carlone; B S Fields; J Guarner; M R Hammerschlag; L A Jackson; C C Kuo; M Maass; T O Messmer; D F Talkington; M L Tondella; S R Zaki
Journal:  Clin Infect Dis       Date:  2001-07-20       Impact factor: 9.079

3.  Chlamydia pneumoniae and its proposed link to multiple sclerosis: to be or not to be?

Authors:  C A Gaydos
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

4.  Infection with Chlamydia pneumoniae and risk of multiple sclerosis.

Authors:  Kassandra L Munger; Rosanna W Peeling; Miguel A Hernán; Lisa Chasan-Taber; Michael J Olek; Susan E Hankinson; David Hunter; Alberto Ascherio
Journal:  Epidemiology       Date:  2003-03       Impact factor: 4.822

5.  Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis.

Authors:  J Gieffers; D Pohl; J Treib; R Dittmann; C Stephan; K Klotz; F Hanefeld; W Solbach; A Haass; M Maass
Journal:  Ann Neurol       Date:  2001-05       Impact factor: 10.422

Review 6.  Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells.

Authors:  J Boman; C A Gaydos
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

7.  Comparative study of the presence of Chlamydia pneumoniae in cerebrospinal fluid of Patients with clinically definite and monosymptomatic multiple sclerosis.

Authors:  Subramaniam Sriram; Song-Yi Yao; Charles Stratton; Peter Calabresi; William Mitchell; Hideaki Ikejima; Yoshimasa Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

8.  Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR.

Authors:  C Y Tong; M Sillis
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

9.  Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis.

Authors:  S Sriram; C W Stratton; S Yao; A Tharp; L Ding; J D Bannan; W M Mitchell
Journal:  Ann Neurol       Date:  1999-07       Impact factor: 10.422

10.  Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis.

Authors:  Q Hao; N Miyashita; M Matsui; H Y Wang; T Matsushima; T Saida
Journal:  Mult Scler       Date:  2002-10       Impact factor: 6.312
View more
  2 in total

Review 1.  Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?

Authors:  Kensuke Shima; Gregor Kuhlenbäumer; Jan Rupp
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

Review 2.  In-house nucleic acid amplification assays in research: how much quality control is needed before one can rely upon the results?

Authors:  Petra Apfalter; Udo Reischl; Margaret R Hammerschlag
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.